Zobrazeno 1 - 6
of 6
pro vyhledávání: '"G. Karamouzis"'
Gastric cancer, the fifth most frequent cancer and the fourth leading cause of cancer deaths, accounts for a devastating death rate worldwide. Since the majority of patients with gastric cancer are diagnosed at advanced stages, they are not suitable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::26dfae892ce8078520398154a3c57315
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3003178
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3003178
Cholangiocarcinomas (CCAs) are diverse biliary epithelial tumours involving the intrahepatic, perihilar and distal parts of the biliary tree. The three entirely variable entities have distinct epidemiology, molecular characteristics, prognosis and st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::454403d1837f65692379586221784c72
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3032129
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3032129
Publikováno v:
Scandinavian Journal of Medicine & Science in Sports. 4:113-118
The purpose of this study was to determine the resting values of growth hormone (GH) and testosterone (T) within prepubertal, pubertal and adolescence ages and to compare the effects of physical training in each age, in 2 groups. The exercise group (
Many cytotoxic agents used in cancer treatment exert their effects through their ability to directly or indirectly damage DNA and thus resulting in cell death. Major types of DNA damage induced by anticancer treatment include strand breaks (double or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::c255fdca004a9a130adb6e6e9b53fc32
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3147608
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3147608
Autor:
Ardavanis, A Tryfonopoulos, D Orfanos, G Karamouzis, M and Scorilas, A Alexopoulos, A Rigatos, G
Background: Trastuzumab has been repeatedly shown to result in significant clinical benefits and was subsequently accepted as the treatment of choice for HER2-positive advanced breast cancer - particularly as first-line treatment in combination with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::9a286b4dd66461174d14128295d382b4
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3093089
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3093089
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.